Medical News Today -
3 Mar 2014 12:00
A study by researchers from the Institute for Bioengineering of Catalonia (IBEC) and the Barcelona Centre for International Health Research (CRESIB) demonstrates that an antimalarial drug encapsulated in nanoparticles - chloroquine salts in polyamidoamine polymers - is significantly more effective when delivered in vivo than free (unencapsulated) drugs and may help to curb drug resistance.
Share this Article